The balance sheet and cashflows of this company would have to be near perfect. Quite exemplary really.Question is, how much is one willing to pay for such a specimen... its currently a 20x or more earnings..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025